Comparative Effectiveness of Tirzepatide and Semaglutide in Individuals at Cardiovascular Risk

Clinical trial NCT07096063 · COMPLETED

Trial details

NCT number: NCT07096063
Sponsor: Brigham and Women's Hospital
Status: COMPLETED
Study type: OBSERVATIONAL

Type 2 Diabetes Overweight Cardiovascular (CV) Risk

Start date: 2024-10-01
Primary completion: 2025-07-15
Enrollment: 887132

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.